Table 2.
Associations of multimorbidity measures with healthcare utilization and expenditures among CHARLS participants with diabetes, overall and by sex.
| Multimorbidity measure | Inpatient care utilization | Outpatient care utilization | Number of hospitalizations | Number of outpatient visits | Total inpatient expenditure | Out-of-pocket inpatient expenditure | Total outpatient expenditure | Out-of-pocket outpatient expenditure |
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | Count ratio (95% CI) | Count ratio (95% CI) | Cost ratio (95% CI) | Cost ratio (95% CI) | Cost ratio (95% CI) | Cost ratio (95% CI) | |
| Overall | ||||||||
| Multimorbidity | 2.22 (1.46–3.52) | 2.95 (1.84–5.04) | 2.87 (1.69–5.38) | 2.75 (1.42–6.31) | 2.31 (1.31–6.27) | 2.81 (1.54–7.40) | 5.16 (2.34–22.49) | 5.46 (2.75–15.39) |
| ≥3 long-term conditions | 2.44 (1.90–3.16) | 2.17 (1.68–2.84) | 2.48 (1.87–3.37) | 2.09 (1.48–3.04) | 2.98 (1.94–5.24) | 2.39 (1.27–5.52) | 3.15 (1.92–5.72) | 3.10 (1.92–5.06) |
| Number of long-term conditions | 1.25 (1.19–1.30) | 1.22 (1.17–1.28) | 1.21 (1.16–1.25) | 1.15 (1.09–1.21) | 1.24 (1.15–1.32) | 1.23 (1.14–1.33) | 1.35 (1.22–1.47) | 1.29 (1.18–1.39) |
| Chinese multimorbidity-weighted index | 1.12 (1.09–1.14) | 1.08 (1.06–1.11) | 1.10 (1.08–1.12) | 1.07 (1.04–1.09) | 1.13 (1.09–1.17) | 1.14 (1.09–1.18) | 1.15 (1.09–1.20) | 1.12 (1.07–1.17) |
| Male | ||||||||
| Multimorbidity | 3.01 (1.65–6.07) | 2.55 (1.39–5.15) | 3.89 (1.77–11.07) | 2.18 (0.89–7.35) | 2.01 (0.68–16.33) | 2.58 (0.76–18.71) | 5.43 (2.42–34.25) | 3.42 (1.53–18.56) |
| ≥3 long-term conditions | 2.57 (1.80–3.73) | 2.56 (1.75–3.83) | 2.77 (1.84–4.38) | 2.70 (1.51–5.33) | 3.01 (1.62–6.93) | 3.63 (1.95–8.22) | 3.80 (1.96–9.19) | 3.01 (1.67–6.44) |
| Number of long-term conditions | 1.28 (1.20–1.37) | 1.23 (1.15–1.32) | 1.21 (1.14–1.28) | 1.09 (0.99–1.20) | 1.27 (1.13–1.42) | 1.32 (1.17–1.46) | 1.31 (1.15–1.46) | 1.21 (1.11–1.35) |
| Chinese multimorbidity-weighted index | 1.14 (1.10–1.18) | 1.10 (1.06–1.14) | 1.11 (1.08–1.14) | 1.05 (1.01–1.10) | 1.14 (1.09–1.20) | 1.17 (1.11–1.23) | 1.14 (1.06–1.21) | 1.11 (1.04–1.17) |
| Female | ||||||||
| Multimorbidity | 1.61 (0.91–3.04) | 3.63 (1.76–8.80) | 2.14 (1.11–4.89) | 3.80 (1.51–13.93) | 1.81 (0.84–5.98) | 1.88 (0.80–6.37) | 4.51 (1.60–88.58) | 5.31 (1.81–47.16) |
| ≥3 long-term conditions | 2.32 (1.64–3.35) | 1.91 (1.36–2.76) | 2.25 (1.55–3.42) | 1.74 (1.18–2.68) | 2.72 (1.50–5.90) | 1.66 (0.76–5.28) | 2.77 (1.44–6.93) | 3.00 (1.61–6.35) |
| Number of long-term conditions | 1.22 (1.15–1.30) | 1.22 (1.15–1.30) | 1.20 (1.14–1.26) | 1.19 (1.13–1.27) | 1.21 (1.13–1.31) | 1.14 (1.04–1.27) | 1.36 (1.21–1.52) | 1.31 (1.18–1.48) |
| Chinese multimorbidity-weighted index | 1.10 (1.07–1.14) | 1.07 (1.04–1.10) | 1.09 (1.06–1.12) | 1.08 (1.04–1.11) | 1.12 (1.07–1.16) | 1.09 (1.04–1.15) | 1.15 (1.08–1.22) | 1.12 (1.06–1.20) |
| P for interaction by sex | ||||||||
| Multimorbidity × sex | 0.124 | 0.621 | 0.240 | 0.549 | 0.326 | 0.250 | 0.318 | 0.658 |
| ≥3 long-term conditions × sex | 0.601 | 0.190 | 0.400 | 0.180 | 0.864 | 0.092 | 0.381 | 0.500 |
| Number of long-term conditions × sex | 0.256 | 0.686 | 0.681 | 0.182 | 0.684 | 0.038 | 0.847 | 0.295 |
| Chinese multimorbidity-weighted index × sex | 0.126 | 0.129 | 0.195 | 0.642 | 0.498 | 0.017 | 0.286 | 0.188 |
Binary utilization outcomes were analyzed using logistic regression, and visit counts using quasi-Poisson regression with a log link. Expenditure outcomes were analyzed using two-part models combining logistic regression and Gamma regression with a log link; cost ratios represent ratios of standardized overall mean expenditure, including zero expenditure. Models were adjusted for age, education, residence, marital status, health insurance, and diabetes control, with additional adjustment for sex in overall analyses. Sex-stratified analyses and interaction tests were exploratory; interaction p values were unadjusted for multiple testing. CHARLS, China Health and Retirement Longitudinal Study; OR, odds ratio; CI, confidence interval.